Early and Late Stage Clinical Trials for the Spectrum of Alzheimers Disease/Alzheimers Related Dementias and Age-Related Cognitive Decline (R01 Clinical Trial Optional) (345098)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

Next deadline: Jun 5, 2023

Later deadlines: Jul 5, 2023, Oct 5, 2023, Nov 5, 2023, Feb 5, 2024, Mar 5, 2024, Jun 5, 2024, Jul 5, 2024, Oct 5, 2024, Nov 5, 2024

Grant amount: Unspecified amount

Funding uses: Research

Location of project: Anywhere in the world

Location of residency: Anywhere in the world

Overview:

NOTE: The following deadlines apply to standard grant applications (due by 5:00 pm  local time of applicant organization):

• February 5,2023 
• June 5, 2023
• October 5, 2023
• February 5, 2024
• June 5, 2024
• October 5, 2024

The following deadlines apply to AIDS-related grant applications (due by 5:00 pm local time of applicant organization): 

• March 5, 2023 
• July 5, 2023
• November 5, 2023
• March 5, 2024
• July 5, 2024
• November 5, 2024

The purpose of this Funding Opportunity Announcement (FOA) is to 1) invite applications that propose to develop and implement early to late stage clinical trials of promising pharmacological and non-pharmacological interventions for cognitive and neuropsychiatric changes associated with age-related cognitive decline and Alzheimer's disease (AD) and Alzheimer's disease-related Dementias (ADRD) across the spectrum from pre-symptomatic to more severe stages of disease, and 2) stimulate studies to enhance trial design and methods.

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.